Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

ACCEL DIAGNOSTICS, LLC

UEI: QUJ4EFCK59N4CAGE: 5G0E4

ACCEL DIAGNOSTICS, LLC is a federal contractor, registered under UEI QUJ4EFCK59N4 and CAGE code 5G0E4. It has been awarded $4,925,483 in federal contracts. Primary work spans Unknown NAICS, Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology), and Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology). Top awarding agencies include Department Of Health And Human Services.

Contact Information

Registration and classification details

Registration

UEI Code

QUJ4EFCK59N4

CAGE Code

5G0E4

Entity Structure

Corporate Entity (Not Tax Exempt)

Established

N/A

Business Classifications

For Profit OrganizationLimited Liability Company

NAICS Codes

334516Analytical Laboratory Instrument Manufacturing
541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)(Primary)
621511Medical Laboratories

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

ACCEL DIAGNOSTICS, LLC specializes in translational research and development focused on diagnostic technologies for cardiotoxicity assessment in oncology patients. Their core expertise lies in designing minimally invasive diagnostic assays that detect early biomarkers of chemotherapy-induced cardiac...

ACCEL DIAGNOSTICS, LLC specializes in translational research and development focused on diagnostic technologies for cardiotoxicity assessment in oncology patients. Their core expertise lies in designing minimally invasive diagnostic assays that detect early biomarkers of chemotherapy-induced cardiac damage, leveraging advanced molecular diagnostics, bioanalytical validation, and clinical data integration. The company’s technical capabilities include biomarker discovery, assay development for low-volume clinical samples, and validation of point-of-care diagnostic platforms compliant with clinical laboratory standards. Their work bridges laboratory innovation with clinical applicability, emphasizing patient safety in cancer therapy through precision monitoring tools. A key differentiator is their focus on non-invasive, high-sensitivity detection methods that reduce patient burden while improving therapeutic decision-making. The contractor has demonstrated direct experience supporting the Department of Health and Human Services, specifically through SBIR Phase II funding initiatives focused on high-impact health technologies. Their engagement with HHS reflects a targeted alignment with NIH and FDA priorities in early diagnostic innovation, particularly in oncology and cardio-oncology. The relationship suggests a pattern of collaboration on federally funded research programs aimed at translating preclinical findings into clinically viable diagnostic solutions. ACCEL DIAGNOSTICS operates primarily under NAICS 541715, which encompasses applied research in life sciences excluding biotechnology and nanotechnology. In practice, this means they develop analytical tools and diagnostic protocols grounded in biochemical, pharmacological, and clinical science—positioning them as a niche player in the precision diagnostics market for oncology support therapies. Their market focus is on bridging the gap between academic research and regulatory-ready medical devices. As a small business structured as a 2L entity based in Houston, Texas, ACCEL DIAGNOSTICS is positioned as a specialized R&D firm without formal government certifications. Their geographic presence supports regional life sciences ecosystems, and their government market positioning centers on competitive SBIR/STTR programs that fund high-risk, high-reward diagnostic innovations.

Key performance metrics

Award counts and award dollars by type, as prime and as subcontractor.

Awards Count

9

All time

Active

0

Currently performing

Completed

9

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award analytics

Awards by agency, industry, year, award type, size, and place of performance.

Awards by Agency
Awards by NAICS
Awards by Agency Over Time
Awards by Place of Performance

Compete with ACCEL DIAGNOSTICS, LLC

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for ACCEL DIAGNOSTICS, LLC

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in ACCEL DIAGNOSTICS, LLC's top NAICS codes and agencies

NAICS: 541715
New
Federal
Venous Thrombosis (VT)
Solicitation # 80JSC026Q0014
Solicitation 80JSC026Q0014 is a combined synopsis and request for quotations issued by the NASA Johnson Space Center for a firm-fixed-price contract. The project seeks applied research and the development of current or novel approaches to surveil, reduce risk of, and prevent or treat venous thrombosis during spaceflight and exploration missions. The scope of work encompasses preflight medical screening, individual risk assessments, monitoring approaches, and both prophylactic and treatment countermeasures. Specifically excluded from this requirement are pharmaceutical treatments, AI/ML modeling, Earth-independent decision-making tools, and tissue chip or organoid pathophysiology development. The contract features a base period of performance from January 7, 2027, to September 30, 2031, with four optional years. This is a full and open competition for commercial products under NAICS code 541715. Award decisions will be based on a two-step evaluation process consisting of a compliance check followed by a trade-off analysis. Technical acceptability and past performance are weighted as significantly more important than price. Proposals must adhere to Dual-Anonymous Peer Review guidelines, separating attributable information from the technical quote. All responses must be submitted electronically by 1:00 PM CST on November 20, 2026, with technical and contractual questions due by October 30, 2026.
NASA Johnson Space Center

POSTED

1 day ago

DEADLINE

in 10 days
View Details
NAICS: 541715
New
Federal
ACC-DTA Commercial Solutions Opening (CSO)
Solicitation # W912CH-26-S-0001
The Army Contracting Command – Detroit Arsenal (ACC-DTA) Commercial Solutions Opening (CSO), solicitation W912CH-26-S-0001, serves as a rapid-acquisition gateway to transition innovative commercial technologies into active defense programs. Supporting a diverse customer base including the Intelligence and Security Command (INSCOM) and six Portfolio Acquisition Executives, this vehicle focuses on enhancing the development, integration, and sustainment of ground vehicle systems to improve Army modernization and readiness. The CSO utilizes a streamlined, merit-based, multi-phased evaluation process consisting of solution briefs, presentations, and commercial solution proposals. Awards may be issued through 2028 as FAR Part 12 commercial contracts, non-FAR transaction agreements under 10 U.S.C. 4022, or Cooperative Agreements under 31 U.S.C. 6305. The scope of the CSO is broad and evolves through frequent amendments, encompassing various Areas of Interest (AoI). Key initiatives include the FALCONS prototype effort for long-range reconnaissance sensors with funding ceilings up to 30 million dollars, the TIGER Readiness and Hackathon programs focused on Abrams Main Battle Tank engine supply chain resilience, and the procurement of Mobile Camouflage Systems, Counter-UAS detection, and domestically produced hand tools. Evaluation is based on technical merit, the realism of the performance schedule, and price affordability. To be eligible for award, companies must be registered in the System for Award Management (SAM) with a Unique Entity ID and must comply with the Buy American Act and Specialty Metals clauses.
W6QK Acc- Dta

POSTED

1 day ago

DEADLINE

in about 2 years
View Details
NAICS: 541715
New
Federal
Systems for Phenotypic Evaluation, Clinical Trajectories, Response, and Agency (SPECTRA)
Solicitation # ARPA-H-SOL-26-163
The Systems for Phenotypic Evaluation, Clinical Trajectories, Response, and Agency (SPECTRA) program, issued by the Advanced Research Projects Agency for Health (ARPA-H) Proactive Health Office under solicitation ARPA-H-SOL-26-163, seeks innovative solutions to identify and act upon autism trajectories across the lifespan. The program focuses on the nonlinear interactions of genetic, biological, behavioral, and environmental factors to move toward personalized care. The scope is divided into four Technical Areas: TA1 focuses on multi-factor analysis and trajectory identification; TA2 involves population-scale modeling and data integration; TA3 centers on precision intervention and trajectory testing; and TA4 targets technologies for communication, quality of life, and embedded assessment. Awards will be made using Other Transaction (OT) instruments through a two-stage submission process consisting of a Solution Summary and a Full Proposal. Technical performance is monitored via a milestone-based system with evaluation gates at Month 10, Month 22, and a final evaluation at Month 46. Key requirements include strict adherence to HIPAA Privacy Rule de-identification standards, the implementation of independent data safety monitoring boards for harm surveillance, and the disclosure of any organizational conflicts of interest. Submissions must follow specific formatting guidelines, including the use of Avenir Next LT Pro font for summaries and a multi-volume structure for full proposals, with a response deadline of December 2, 2026.
Advanced Research Projects Agency For Health (arpa-H)

POSTED

1 day ago

DEADLINE

in 22 days
View Details
NAICS: 541715
New
Federal
Exploratory Advanced Research (EAR) Program FY 2027 Data Science Solicitation
Solicitation # 693JJ3-27-BAA-0002
The Exploratory Advanced Research (EAR) Program FY 2027 Data Science Solicitation, identified as 693JJ3-27-BAA-0002, is a Broad Agency Announcement issued by the Federal Highway Administration (FHWA) within the Department of Transportation. The program seeks to identify and fund high-risk, high-payoff research focused on applying emerging and advanced data analytic techniques to improve the safety, durability, efficiency, and environmental impact of highway and intermodal transportation systems. Key objectives include expanding the community of researchers in data science for transportation and increasing the availability of well-documented highway transportation data. The expected period of performance for awarded projects is 60 months, with most instruments anticipated to be firm-fixed-price contracts, although cost-reimbursement arrangements may be permitted for awardees with approved accounting systems. The government will utilize a best-value determination based on an integrated evaluation of technical capability, past performance, and cost/price. Technical capability is the most important non-price factor, and combined non-price factors are approximately equal in weight to cost/price. The selection process involves a two-phase approach, beginning with a project concept paper rated as acceptable or not acceptable, followed by a formal project proposal. While there are no exclusive set-asides, the solicitation strongly encourages submissions from small businesses, including disadvantaged, veteran-owned, and woman-owned concerns, as well as Historically Black Colleges and Universities and Minority Institutions. Proposals must be submitted in electronic PDF format and organized into three volumes: a technical proposal with a 20-page limit, cost and pricing data, and supplemental information regarding intellectual property. Key requirements include registration in the System for Award Management (SAM), the provision of a Unique Entity Identifier (UEI), and the submission of a Small Business Subcontracting Plan for non-small business entities with awards exceeding 900,000 dollars. Additionally, the FHWA will maintain unlimited rights to any software and source code delivered under the contract. The response deadline for this solicitation is December 21, 2026.
693JJ3 Acquisition And Grants Mgt

POSTED

1 day ago

DEADLINE

in about 1 month
View Details